Cellular angiofibroma is a rare benign mesenchymal tumor reported in genital region in middle-aged patients. We report a rare presentation of the tumor in an extragenital location-the arm of a young male patient. After biopsy, an en bloc excision of the mass was done and diagnosis was confirmed. No adjuvant treatment was required. Our patient had an unusual location for this rare tumor at an age younger than reported in literature so far. Imaging can only predict the mesenchymal nature of the tumor but histopathology and immunohistochemistry (IHC) is the cornerstone of diagnosis. Cellular angiofibroma has a good prognosis. Histopathology and IHC are needed to confirm the diagnosis, hence emphasizing the role of a good and experienced pathologist. The pathogenesis of the cellular angiofibroma is still not fully determined and current hormonal and immunotherapy suppression regimes will need further evaluation.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.4103/jcrt.jcrt_843_22 | DOI Listing |
J Pers Med
December 2024
Radiological Sciences Section, Department of Biomedicine, Neuroscience and Advanced Diagnostics, University of Palermo, AOUP "Paolo Giaccone", Via del Vespro 129, 90127 Palermo, Italy.
Nasal and paranasal sinus masses can arise from a wide range of conditions, both benign and malignant, as well as congenital or acquired. Diagnosing these masses is often challenging, requiring a combination of nasal endoscopy, imaging studies, and histopathological analysis. Initial imaging frequently involves computed tomography or cone beam computed tomography (CBCT) to evaluate the bony anatomy of the nasal cavity and surrounding sinuses, while magnetic resonance imaging (MRI) is typically used for detailed assessment of soft tissues and to aid in differential diagnosis when the findings are inconclusive.
View Article and Find Full Text PDFMol Genet Genomics
December 2024
Department of Medical Genetics, Faculty of Medicine, Karadeniz Technical University, Trabzon, Turkey.
Tuberous sclerosis complex (TSC) is a rare genetic disorder characterized by the formation of benign tumors in various organs, particularly in the central nervous system. We aimed to delineate the molecular profile of Turkish individuals diagnosed with TSC by analyzing the TSC1 and TSC2 genes using next-generation sequencing (NGS). Sophia Genetics' Sophia Inherited Disease Panel was used to perform NGS on 22 individuals diagnosed with TSC and to identify pathogenic variants in the TSC1 and TSC2 genes.
View Article and Find Full Text PDFBackground: Primary cardiac tumors (PCT), such as myxoma, are rare and predominantly benign. Angiofibroma tumors are an extremely rare subtype of PCT, reported in less than ten cases. In this study, we presented a mixed tumor of myxoma and angiofibroma for the first time in the human heart.
View Article and Find Full Text PDFCureus
November 2024
Otolaryngology-Head and Neck Surgery, Bedfordshire Hospitals NHS Trust, Bedfordshire, GBR.
Objective: To present clinical experiences in managing sphenoid sinus lesions at Al Nahdha Hospital, Oman with a focus on diagnostic challenges and surgical outcomes.
Methods: A retrospective analysis was conducted on six cases of sphenoid sinus lesions treated with endoscopic sinus surgery (ESS). Diagnostic modalities included contrast-enhanced computed tomography (CT) and magnetic resonance imaging (MRI), followed by histopathological confirmation.
J Midlife Health
October 2024
Department of Obstetrics and Gynaecology, All India Institute of Medical Sciences, Jodhpur, Rajasthan, India.
Cellular angiofibroma (CA) is a relatively recently described, rare, benign soft tissue tumor that predominantly occurs in the vulvoperineal region. It was first described in 1997 as a mesenchymal-origin tumor composed of connective (fibrous) tissue and blood vessels. We report a case of vaginal CA in a 40-year-old woman who presented with pressure symptoms, incidentally diagnosed with a vaginal mass and clinically suspected as vaginal myoma.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!